| Health Care Medical | |
| 625 S Pear Orchard Rd, Ridgeland, Mississippi 39157 | |
| (601) 420-0064 |
| Name | Health Care Medical |
|---|---|
| Organization Name | Tolley Valerie |
| Location | 625 S Pear Orchard Rd, Ridgeland, Mississippi 39157 |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Phone | (601) 420-0064 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.
iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.
› Verified 9 days ago
| NPI Number | 1356541841 |
| Organization Name | HEALTH CARE MEDICAL RESPIRATORY & REHAB |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 371 Towne Center Blvd, Ridgeland, MS 39157 |
| Phone Number | 601-420-0064 |
News Archive
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.
iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.
› Verified 9 days ago
| NPI Number | 1407104391 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 625 S Pear Orchard Rd, Ridgeland, MS 39157 |
| Phone Number | 601-420-0064 |
News Archive
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.
iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.
› Verified 9 days ago
| NPI Number | 1851595672 |
| Organization Name | HEALTH CARE MEDICAL |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 371 Towne Center Blvd, Ridgeland, MS 39157 |
| Phone Number | 601-420-0064 |
News Archive
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.
iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.
› Verified 9 days ago
News Archive
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.
iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.
› Verified 9 days ago
Homecare Plus Inc Type: Pharmacy Location: 864 Wilson Dr, Ridgeland, Mississippi 39157 Phone: (601) 957-9174 | |
Cvs Pharmacy #05925 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1600 E County Line Rd, Ridgeland, Mississippi 39157 Phone: (601) 957-1874 | |
Total Healthcare Solutions Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7048 Old Canton Rd, Ridgeland, Mississippi 39157 Phone: (601) 919-0972 | |
Walgreens #5655 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6970 Old Canton Rd, Ridgeland, Mississippi 39157 Phone: (601) 956-3844 | |
Health Care Medical Type: DME Supplier - Oxygen Equipment & Supplies Location: 625 S Pear Orchard Rd, Ridgeland, Mississippi 39157 Phone: (601) 420-0064 |